Search research articles
Contact Us
Filters
Showing results (11-20 of 221) with videos related to
Page
of 23
Sort By:
Expert Opinion on Biological Therapy
|
June 15, 2005
Interferon alpha for the treatment of advanced renal cancer
Alain Ravaud, Marie-Sarah Dilhuydy
Bulletin Du Cancer
|
February 16, 2002
[Update on renal cell carcinoma]
Alain Ravaud, Jacques-Olivier Bay
Bulletin Du Cancer
|
September 13, 2007
[Cancer of the prostate: recent findings and the immediate future]
Alain Ravaud, Jacques-Olivier Bay
Cancer Treatment Reviews
|
February 15, 2012
Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma
Alain Ravaud, Marine Gross-Goupil
Translational Andrology and Urology
|
January 28, 2016
Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?
Marine Gross-Goupil, Alain Ravaud
Anti-Cancer Drugs
|
March 12, 2011
Exposure-response relationships in patients with metastatic renal cell carcinoma receiving sunitinib: maintaining optimum efficacy in clinical practice
Alain Ravaud, Carlo L Bello
Therapeutic Advances in Urology
|
October 2, 2012
Experience with sunitinib in the treatment of metastatic renal cell carcinoma
Manuela Schmidinger, James Larkin, Alain Ravaud
Cancer Treatment Reviews
|
July 27, 2012
What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI?
Emiliano Calvo, Alain Ravaud, Joaquim Bellmunt
Clinical Genitourinary Cancer
|
February 15, 2014
Pulmonary aspergilloma: an unexpected complication of radiofrequency ablation in the management of targeted therapy for a patient with metastatic renal cell carcinoma
Amaury Daste, Marine Gross-Goupil, Alain Ravaud
European Urology
|
November 12, 2017
Reply to Francesco Massari, Vincenzo Di Nunno, and Andrea Ardizzoni's Letter to the Editor re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol 2018;73:62-8
Robert J Motzer, Bernard Escudier, Alain Ravaud
Page
of 23
Search research articles
Search
Showing results (11-20 of 221) with videos related to
Sort By:
Page
of 23
Expert Opinion on Biological Therapy
|
June 15, 2005
Interferon alpha for the treatment of advanced renal cancer
Alain Ravaud, Marie-Sarah Dilhuydy
Bulletin Du Cancer
|
February 16, 2002
[Update on renal cell carcinoma]
Alain Ravaud, Jacques-Olivier Bay
Bulletin Du Cancer
|
September 13, 2007
[Cancer of the prostate: recent findings and the immediate future]
Alain Ravaud, Jacques-Olivier Bay
Cancer Treatment Reviews
|
February 15, 2012
Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma
Alain Ravaud, Marine Gross-Goupil
Translational Andrology and Urology
|
January 28, 2016
Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?
Marine Gross-Goupil, Alain Ravaud
Anti-Cancer Drugs
|
March 12, 2011
Exposure-response relationships in patients with metastatic renal cell carcinoma receiving sunitinib: maintaining optimum efficacy in clinical practice
Alain Ravaud, Carlo L Bello
Therapeutic Advances in Urology
|
October 2, 2012
Experience with sunitinib in the treatment of metastatic renal cell carcinoma
Manuela Schmidinger, James Larkin, Alain Ravaud
Cancer Treatment Reviews
|
July 27, 2012
What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI?
Emiliano Calvo, Alain Ravaud, Joaquim Bellmunt
Clinical Genitourinary Cancer
|
February 15, 2014
Pulmonary aspergilloma: an unexpected complication of radiofrequency ablation in the management of targeted therapy for a patient with metastatic renal cell carcinoma
Amaury Daste, Marine Gross-Goupil, Alain Ravaud
European Urology
|
November 12, 2017
Reply to Francesco Massari, Vincenzo Di Nunno, and Andrea Ardizzoni's Letter to the Editor re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol 2018;73:62-8
Robert J Motzer, Bernard Escudier, Alain Ravaud
Page
of 23